Wells Fargo & Company Heart Test Laboratories, Inc. Transaction History

Wells Fargo & Company

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.11 - $0.18 $42 - $70	389 Added 607.81%	453 $0
Q4 2023 Feb 09, 2024	BUY	$0.15 - $0.43 $1 - $3	7 Added 12.28%	64 $0
Q3 2023 Nov 13, 2023	BUY	$0.38 - $0.98 $13 - $34	35 Added 159.09%	57 $0
Q2 2023 Aug 15, 2023	BUY	$0.83 - $1.26 $9 - $13	11 Added 100.0%	22 $0
Q4 2022 Feb 13, 2023	BUY	$0.8 - $267.0 $0 - $267	1 Added 10.0%	11 $0
Q3 2022 Nov 14, 2022	BUY	$1.15 - $126.0 $11 - $1,260	10 New	10 $0

Ticker HSCS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 8,202,550
Market Cap $23.8M
Description
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urg...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.